September 8, 2003 - Rezulin Lawsuits May Be
Getting Harder to Fight Off
New findings published in the Mayo clinic Proceedings
show that diabetes drugs may cause heart failure and cause fluid
buildup in some patients. Read Full Article...
April 22, 2003 - Pfizer must defend Rezulin lawsuit
An appeal court reinstated a Rezulin lawsuit that was dismissed
in October 2001 in a lower court. The Rezulin lawsuit alleged that
Pfizer’s Warner-Lambert unit hid Rezulin safety risks and
continued to aggressively market Rezulin despite the serious liver
damages being reported. Rezulin class action lawsuit status is currently
being sought for the damages suffered by Rezulin patients.
April 22, 2003 - Rezulin fraud suit
Rezulin Type II diabetes drug was seen as progress in treatment
options when it was first introduced to the market in 1997. Forced
to make Rezulin labeling changes several times, Rezulin was associated
to liver failure and liver injury, leading up to the March 2000
announcement of a Rezulin recall.
A fraud suit was brought against Rezulin drug makers by health
insurance companies that charged the Rezulin company continued to
claim it was safe despite reporting to the FDA that 31 Rezulin users
had died in a 6-month period in 1998 and that the Rezulin company
continued to lie as more and more adverse Rezulin reports were made.
A Southern District of New York judge had dismissed the Rezulin
case in October 2001. Now, the 2nd U.S. circuit Court of Appeals
has reversed the decision. The 2nd Circuit court disagreed with
the previous judge’s decision, a victory for Rezulin users
that had suffered serious and deadly Rezulin side effects.
a Rezulin Lawyer for more lawsuit information
April 18, 2003 - Hispanics informed of Rezulin lawsuit
A high number of diabetic patients that used Rezulin prior to the
March 2000 recall have been filing Rezulin lawsuits for the deadly
and serious effects Rezulin caused. A June 2002 L.A. Times article
was written stating legal documents exist showing that Warner Lambert
targeted Latinos while marketing Rezulin, as well as paying doctors
to have their diabetic patients switch to using Rezulin. Now, Hispanic
Rezulin patients are becoming better informed of how the judicial
system can help recover damages for the serious Rezulin side effects
April 3, 2003 - Manhattan jury rules against Rezulin company
A $2 million verdict favored a former Rezulin patient that suffered
Rezulin side effects, unanimously deciding there was “clear
and convincing” evidence showing Warner-Lambert misrepresented
or omitted Rezulin material information to physicians. At the time
of the Rezulin recall there had been around one hundred people that
either died or suffered from acute liver failure that required liver
transplant because of Rezulin diabetes drug. Pfizer (which acquired
Warner-Lambert in June 2000) is appealing the Rezulin decision.
The world’s largest drug maker, Pfizer has had thousands of
Rezulin lawsuits filed against the company.
March 31, 2003 - Rezulin class action lawsuit denied
In September 2002, U.S. judge denied a nationwide Rezulin class
action lawsuit and now a California appeals court denied a Rezulin
class action lawsuit for California residents as well. Although
this may appear a small victory for Pfizer, the world’s largest
drug company has had thousands of Rezulin lawsuits filed against
them, paying $11.5 million, $23.6 million, and $2 million for Rezulin
lawsuits the company lost, in addition to paying $43 million to